Botox-Maker Finds its Suitor
Actavis to pay $66 billion for Allergan.
Morning Money Memo… Less than two weeks after the Comcast – Time Warner Cable deal, there’s another big buyout in the works. Drugmaker Actavis has announced it will purchase rival Forest Laboratories in a cash-and-stock deal worth about $25 billion. Actavis is known for making...
After complications from surgery to remove a benign cyst near his brain and spine, 2-year-old Harrison Kothari seemed to be recovering well. "He was supposed to get discharged the next day," said Shanoop Kothari, Harrison's father. But on December 1, Harrison's organs began failing from acute
WEDNESDAY, Jan. 28 (HealthDay News) -- The U.S. Food and Drug Administration has approved Watson Pharmaceuticals' Gelnique (oxybutynin chloride) to treat symptoms of overactive bladder, the company said in a news release. Gelnique is a topical gel that's applied daily to the thigh, abdomen, upper
Here are some of the latest health and medical news developments, compiled by editors of HealthDay: New Immunization Recommendations for Children Unveiled Updated immunization recommendations for flu shots for children have been unveiled by three leading U.S. health groups. The revised 2009
Here are some of the latest health and medical news developments, compiled by editors of HealthDay: Drug Makers Agree to Voluntary Ban on Doctor 'Freebies' The pharmaceutical industry has agreed to a voluntary moratorium on giving doctors branded items that advertise some of the country's most
THURSDAY, Oct. 9 (HealthDay News) -- The once-daily alpha blocker Rapaflo (silodosin) has been approved by the U.S. Food and Drug Administration to treat benign prostatic hyperplasia (BPH), the medical term for an enlarged prostate. BPH is the top reason men visit urologists. Symptoms include
Here are some of the latest health and medical news developments, compiled by editors of HealthDay: U.S. Orders Largest Beef Recall in History In what is being billed as the largest beef recall in the United States, the U.S. Department of Agriculture Sunday ordered the recall of 143 million pounds
WEDNESDAY, Sept. 5 (HealthDay News) -- The U.S. Food and Drug Administration has approved the first generic versions of Coreg (carvedilol), used to treat high blood pressure, chronic heart failure and a post heart attack problem called left ventricular dysfunction. Approval was given to the